HomeELEV • NASDAQ
Elevation Oncology Inc
add
$0.28
5.77%
After Hours:(3.86%)-0.011
$0.27
Closed: May 16, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.84M | 9.85% |
Net income | -14.21M | -32.73% |
Net profit margin | — | — |
Earnings per share | -0.24 | -16.43% |
EBITDA | -10.84M | -9.91% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.66M | -22.48% |
Total assets | 82.22M | -24.54% |
Total liabilities | 35.49M | 7.08% |
Total equity | 46.73M | — |
Shares outstanding | 59.22M | — |
Price to book | 0.38 | — |
Return on assets | -30.48% | — |
Return on capital | -32.05% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -14.21M | -32.73% |
Cash from operations | -12.71M | -32.75% |
Cash from investing | 23.76M | 14.77% |
Cash from financing | -17.00K | -100.06% |
Net change in cash | 11.03M | -73.34% |
Free cash flow | -6.58M | 1.75% |
Previous close
$0.30
Day range
$0.27 - $0.31
Year range
$0.22 - $4.33
Market cap
16.72M USD
Avg Volume
1.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
34
